Molecular mechanism of monoamine toxicity in Parkinson's disease: hypothetical cell death model

M Jimenez del Rio1, C Velez-Pardo

  • 1School of Medicine, University of Antioquia, Medellin, Colombia.

Medical Hypotheses
|May 3, 2000
PubMed

Insights

Parkinson's disease neuronal death causes remain unclear. This study proposes a hypothetical model involving dopamine and metal ions triggering a cell death cascade.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons.
  • The precise mechanisms underlying this neuronal degeneration are not fully understood, despite extensive research.

Purpose of the Study:

  • To propose a hypothetical model explaining the mechanism of neuronal cell death in Parkinson's disease.
  • To investigate the potential roles of dopamine and metal ions in initiating cell death pathways.

Main Methods:

  • Review and synthesis of existing experimental evidence.
  • Development of a hypothetical model integrating biochemical and cellular processes.
  • Analysis of the proposed interactions between dopamine, metal ions, and cellular machinery.

Main Results:

  • A hypothetical model is presented detailing a potential cascade of events leading to neuronal death.
  • Dopamine and specific metal ions are identified as potential triggers for this cascade.
  • The model outlines the ordered activation of cell death machinery.

Conclusions:

  • The proposed model offers a framework for understanding neuronal degeneration in Parkinson's disease.
  • Further experimental validation is required to confirm the proposed mechanisms involving dopamine and metal ions.
  • This model provides new avenues for research into Parkinson's disease etiology and potential therapeutic targets.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...